0.05Open0.05Pre Close0 Volume85 Open Interest2.50Strike Price0.00Turnover280.40%IV147.57%PremiumDec 20, 2024Expiry Date0.00Intrinsic Value100Multiplier22DDays to Expiry0.05Extrinsic Value100Contract SizeAmericanOptions Type0.1739Delta0.3618Gamma20.60Leverage Ratio-0.0041Theta0.0001Rho3.58Eff Leverage0.0006Vega
Connect Biopharma Stock Discussion
NEWS
Connect Biopharma Presents Late-Breaking Abstract at the American Thoracic Society 2024 International Conference on the Positive Rademikibart Data from its Global Phase 2b in Patients with Moderate-to-Severe Asthma
Price target for this stock is 7$ its undervalued .. sooner it will jump to 2.5 to 3$
No comment yet